We are live on ! Find out more
KIA

Kopp Investment Advisors Portfolio holdings

AUM $54.4M
1-Year Est. Return 14.33%
This Fund
S&P 500
This Quarter Est. Return
-1.92%
1 Year Est. Return
+14.33%
3 Year Est. Return
+109.21%
5 Year Est. Return
+340.72%
10 Year Est. Return
–
AUM
$218M
AUM Growth
-$20.8M
Cap. Flow
-$5.97M
Cap. Flow %
-2.74%
Top 10 Hldgs %
57.55%
Holding
77
New
10
Increased
15
Reduced
41
Closed
7

Top Buys

Rank Stock Value
1
SUPN icon
Supernus Pharmaceuticals
SUPN
+$4.44M
2
PTX
Pernix Therapeutics Holdings, Inc.
PTX
+$3.89M
3
PODD icon
Insulet
PODD
+$2.18M
4
ENZ
Enzo Biochem, Inc.
ENZ
+$2.04M
5
STAA icon
STAAR Surgical
STAA
+$1.78M

Top Sells

Rank Stock Value
1
VIAV icon
Viavi Solutions
VIAV
+$3.18M
2
ALU
Alcatel-Lucent
ALU
+$3.16M
3
SPNC
Spectranetics Corp
SPNC
+$2.92M
4
OMCL icon
Omnicell
OMCL
+$2.57M
5
AKRX
Akorn Inc
AKRX
+$1.8M

Sector Composition

Rank Sector Weight
1 Technology 39.63%
2 Healthcare 32.63%
3 Miscellaneous 14.82%
4 Consumer Staples 5.31%
5 Financials 1.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AFL icon
51
Aflac
AFL
$58.4B
$900K 0.41%
28,932
-390
-1% -$12.2K
SPY icon
52
State Street SPDR S&P 500 ETF Trust
SPY
$827B
$900K 0.41%
4,600
– –
XOM icon
53
ExxonMobil
XOM
$643B
$897K 0.41%
8,909
-79
-0.9% -$7.97K
NOV icon
54
NOV
NOV
$7.4B
$889K 0.41%
10,795
-1,188
-10% -$88.5K
TROW icon
55
T. Rowe Price
TROW
$24B
$889K 0.41%
+10,535
New +$860K
IBM icon
56
IBM
IBM
$225B
$837K 0.38%
4,833
-12
-0.2% -$2.16K
GIMO
57
DELISTED
Gigamon Inc.
GIMO
$771K 0.35%
+40,270
New +$727K
CVLT icon
58
Commault Systems
CVLT
$5.82B
$705K 0.32%
+14,340
New +$772K
VTI icon
59
Vanguard Morningstar Total Stock Market ETF
VTI
$689B
$397K 0.18%
3,900
– –
VCSH icon
60
Vanguard Short-Term Corporate Bond ETF
VCSH
$45.1B
$281K 0.13%
3,500
+500
+17% +$40.1K
QQQ icon
61
Invesco QQQ Trust
QQQ
$493B
$254K 0.12%
2,700
– –
NXTM
62
DELISTED
NxStage Medical Inc.
NXTM
$251K 0.12%
17,490
-1,860
-10% -$24.3K
ALKS icon
63
Alkermes
ALKS
$8.2B
$250K 0.11%
4,959
+110
+2% +$5.07K
NPSP
64
DELISTED
NPS PHARMACEUTICALS INC
NPSP
$217K 0.1%
+6,570
New +$190K
MSLI
65
DELISTED
Merus Labs International Inc.
MSLI
$206K 0.09%
+93,485
New +$157K
INTC icon
66
Intel
INTC
$487B
$204K 0.09%
+6,614
New +$181K
AVDL
67
DELISTED
Avadel Pharmaceuticals
AVDL
$166K 0.08%
+11,034
New +$133K
PMCS
68
DELISTED
P M C SIERRA INC
PMCS
$152K 0.07%
20,000
– –
LMAT icon
69
LeMaitre Vascular
LMAT
$1.82B
$123K 0.06%
14,848
+400
+3% +$3.13K
ATEC icon
70
Alphatec Holdings
ATEC
$1.48B
$116K 0.05%
5,922
+160
+3% +$2.69K
BLK icon
71
Blackrock
BLK
$181B
– –
-3,520
Closed -$1.11M
CYTK icon
72
Cytokinetics
CYTK
$10.8B
– –
-10,197
Closed -$97K
REGN icon
73
Regeneron Pharmaceuticals
REGN
$83.2B
– –
-4,451
Closed -$1.34M
VIAV icon
74
Viavi Solutions
VIAV
$9.49B
– –
-399,528
Closed -$3.18M
SPNC
75
DELISTED
Spectranetics Corp
SPNC
– –
-96,420
Closed -$2.92M
1 2
3
4

Similar funds

OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
GX
Greylock XII Menlo Park, California $51.9M AUM 11.52% 1-Year Est. Return
PGA
Premia Global Advisors Coral Gables, Florida $57.9M AUM 2.91% 1-Year Est. Return
SCG
Saban Capital Group Los Angeles, California $59.5M AUM 3.83% 1-Year Est. Return
TCMV
Technology Crossover Management VI Menlo Park, California $59.6M AUM 18.81% 1-Year Est. Return
FCM
Farmstead Capital Management Ridgewood, New Jersey $49M AUM 10.57% 1-Year Est. Return
SAM
Sheffield Asset Management Chicago, Illinois $48.1M AUM 12.96% 1-Year Est. Return
ACP
Aquiline Capital Partners New York $46.9M AUM 5.65% 1-Year Est. Return

Kopp Investment Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, Kopp Investment Advisors held 77 positions worth $218M, down 8.7% from $238M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Kopp Investment Advisors's Q2 2014 filing shows 10 new, 15 increased, 41 reduced and 7 closed positions. Its largest new stake was Pernix Therapeutics Holdings, Inc.: 63,475 shares worth $5.7M. The largest sale was Viavi Solutions, an estimated $3.18M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, down from 47% a quarter earlier, followed by Healthcare and Miscellaneous.

  • Kopp Investment Advisors's largest Q2 2014 buy was Pernix Therapeutics Holdings, Inc.: 63,475 shares worth $5.7M.
  • Kopp Investment Advisors added most to Supernus Pharmaceuticals in Q2 2014, an estimated $4.44M increase.
  • Kopp Investment Advisors's biggest Q2 2014 reduction was Alcatel-Lucent, cutting an estimated $3.16M.
  • Kopp Investment Advisors fully exited Viavi Solutions in Q2 2014, selling an estimated $3.18M.
  • Kopp Investment Advisors's ten largest holdings make up 58% of its $218M portfolio in Q2 2014.
  • Kopp Investment Advisors opened 10 new positions and closed 7 in Q2 2014.
  • Kopp Investment Advisors's portfolio value fell 8.7% quarter-over-quarter to $218M.

Based on Kopp Investment Advisors's 13F filing for Q2 2014, filed 1 Aug 2014.